Medical Care
Global Pharmaceutical Excipients for Non-injection Market Research Report 2025
- May 05, 25
- ID: 228021
- Pages: 93
- Figures: 89
- Views: 4
The global market for Pharmaceutical Excipients for Non-injection was valued at US$ 5614 million in the year 2024 and is projected to reach a revised size of US$ 10640 million by 2031, growing at a CAGR of 9.7% during the forecast period.
Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipients for Non-injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipients for Non-injection.
The Pharmaceutical Excipients for Non-injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Excipients for Non-injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Excipients for Non-injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Dow
Nippon Fine Chemical
Nanjing Well Pharmaceutical
Jiangsu Maxim Biological
NOF
Croda
Jiangsu Poly Pharmaceutical
Er Kang Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Pfanstiehl
Xi'an Libang Pharmaceutical
Zhejiang Tianyushan Medicinal Oil
Segment by Type
Binders
Disintegrants
Lubricants
Fillers
Others
Segment by Application
Tablets
Capsules
Oral Liquids
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Excipients for Non-injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Excipients for Non-injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Pharmaceutical excipients are the inactive substances that are added to a drug formulation to improve its stability, bioavailability, palatability, and other properties. They are generally regarded as safe (GRAS) by regulatory agencies and are used in various dosage forms, such as tablets, capsules, oral liquids, topical creams, and inhalers.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipients for Non-injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipients for Non-injection.
The Pharmaceutical Excipients for Non-injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Excipients for Non-injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Excipients for Non-injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Dow
Nippon Fine Chemical
Nanjing Well Pharmaceutical
Jiangsu Maxim Biological
NOF
Croda
Jiangsu Poly Pharmaceutical
Er Kang Pharmaceutical
Guangzhou Hanfang Pharmaceutical
Pfanstiehl
Xi'an Libang Pharmaceutical
Zhejiang Tianyushan Medicinal Oil
Segment by Type
Binders
Disintegrants
Lubricants
Fillers
Others
Segment by Application
Tablets
Capsules
Oral Liquids
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pharmaceutical Excipients for Non-injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pharmaceutical Excipients for Non-injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Pharmaceutical Excipients for Non-injection Market Overview
1.1 Product Definition
1.2 Pharmaceutical Excipients for Non-injection by Type
1.2.1 Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Binders
1.2.3 Disintegrants
1.2.4 Lubricants
1.2.5 Fillers
1.2.6 Others
1.3 Pharmaceutical Excipients for Non-injection by Application
1.3.1 Global Pharmaceutical Excipients for Non-injection Market Value by Application (2024 VS 2031)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Oral Liquids
1.3.5 Others
1.4 Global Pharmaceutical Excipients for Non-injection Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Excipients for Non-injection Revenue 2020-2031
1.4.2 Global Pharmaceutical Excipients for Non-injection Sales 2020-2031
1.4.3 Global Pharmaceutical Excipients for Non-injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceutical Excipients for Non-injection Market Competition by Manufacturers
2.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharmaceutical Excipients for Non-injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceutical Excipients for Non-injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Date of Enter into This Industry
2.8 Global Pharmaceutical Excipients for Non-injection Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Excipients for Non-injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceutical Excipients for Non-injection Players Market Share by Revenue
2.8.3 Global Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Excipients for Non-injection Market Scenario by Region
3.1 Global Pharmaceutical Excipients for Non-injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2020-2031
3.2.1 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2020-2025
3.2.2 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2026-2031
3.3 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2020-2031
3.3.1 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2020-2025
3.3.2 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2026-2031
3.4 North America Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.4.3 North America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.5.3 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Excipients for Non-injection Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Excipients for Non-injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Excipients for Non-injection Sales by Type (2020-2031)
4.1.1 Global Pharmaceutical Excipients for Non-injection Sales by Type (2020-2025)
4.1.2 Global Pharmaceutical Excipients for Non-injection Sales by Type (2026-2031)
4.1.3 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2020-2031)
4.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2020-2025)
4.2.2 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2026-2031)
4.2.3 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Excipients for Non-injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceutical Excipients for Non-injection Sales by Application (2020-2031)
5.1.1 Global Pharmaceutical Excipients for Non-injection Sales by Application (2020-2025)
5.1.2 Global Pharmaceutical Excipients for Non-injection Sales by Application (2026-2031)
5.1.3 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2020-2031)
5.2 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2020-2031)
5.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2020-2025)
5.2.2 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2026-2031)
5.2.3 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Excipients for Non-injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dow
6.1.1 Dow Company Information
6.1.2 Dow Description and Business Overview
6.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dow Pharmaceutical Excipients for Non-injection Product Portfolio
6.1.5 Dow Recent Developments/Updates
6.2 Nippon Fine Chemical
6.2.1 Nippon Fine Chemical Company Information
6.2.2 Nippon Fine Chemical Description and Business Overview
6.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolio
6.2.5 Nippon Fine Chemical Recent Developments/Updates
6.3 Nanjing Well Pharmaceutical
6.3.1 Nanjing Well Pharmaceutical Company Information
6.3.2 Nanjing Well Pharmaceutical Description and Business Overview
6.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.3.5 Nanjing Well Pharmaceutical Recent Developments/Updates
6.4 Jiangsu Maxim Biological
6.4.1 Jiangsu Maxim Biological Company Information
6.4.2 Jiangsu Maxim Biological Description and Business Overview
6.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolio
6.4.5 Jiangsu Maxim Biological Recent Developments/Updates
6.5 NOF
6.5.1 NOF Company Information
6.5.2 NOF Description and Business Overview
6.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NOF Pharmaceutical Excipients for Non-injection Product Portfolio
6.5.5 NOF Recent Developments/Updates
6.6 Croda
6.6.1 Croda Company Information
6.6.2 Croda Description and Business Overview
6.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Croda Pharmaceutical Excipients for Non-injection Product Portfolio
6.6.5 Croda Recent Developments/Updates
6.7 Jiangsu Poly Pharmaceutical
6.7.1 Jiangsu Poly Pharmaceutical Company Information
6.7.2 Jiangsu Poly Pharmaceutical Description and Business Overview
6.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.7.5 Jiangsu Poly Pharmaceutical Recent Developments/Updates
6.8 Er Kang Pharmaceutical
6.8.1 Er Kang Pharmaceutical Company Information
6.8.2 Er Kang Pharmaceutical Description and Business Overview
6.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.8.5 Er Kang Pharmaceutical Recent Developments/Updates
6.9 Guangzhou Hanfang Pharmaceutical
6.9.1 Guangzhou Hanfang Pharmaceutical Company Information
6.9.2 Guangzhou Hanfang Pharmaceutical Description and Business Overview
6.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.9.5 Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
6.10 Pfanstiehl
6.10.1 Pfanstiehl Company Information
6.10.2 Pfanstiehl Description and Business Overview
6.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolio
6.10.5 Pfanstiehl Recent Developments/Updates
6.11 Xi'an Libang Pharmaceutical
6.11.1 Xi'an Libang Pharmaceutical Company Information
6.11.2 Xi'an Libang Pharmaceutical Description and Business Overview
6.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.11.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Tianyushan Medicinal Oil
6.12.1 Zhejiang Tianyushan Medicinal Oil Company Information
6.12.2 Zhejiang Tianyushan Medicinal Oil Description and Business Overview
6.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolio
6.12.5 Zhejiang Tianyushan Medicinal Oil Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Excipients for Non-injection Industry Chain Analysis
7.2 Pharmaceutical Excipients for Non-injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Excipients for Non-injection Production Mode & Process Analysis
7.4 Pharmaceutical Excipients for Non-injection Sales and Marketing
7.4.1 Pharmaceutical Excipients for Non-injection Sales Channels
7.4.2 Pharmaceutical Excipients for Non-injection Distributors
7.5 Pharmaceutical Excipients for Non-injection Customer Analysis
8 Pharmaceutical Excipients for Non-injection Market Dynamics
8.1 Pharmaceutical Excipients for Non-injection Industry Trends
8.2 Pharmaceutical Excipients for Non-injection Market Drivers
8.3 Pharmaceutical Excipients for Non-injection Market Challenges
8.4 Pharmaceutical Excipients for Non-injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Definition
1.2 Pharmaceutical Excipients for Non-injection by Type
1.2.1 Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 Binders
1.2.3 Disintegrants
1.2.4 Lubricants
1.2.5 Fillers
1.2.6 Others
1.3 Pharmaceutical Excipients for Non-injection by Application
1.3.1 Global Pharmaceutical Excipients for Non-injection Market Value by Application (2024 VS 2031)
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Oral Liquids
1.3.5 Others
1.4 Global Pharmaceutical Excipients for Non-injection Market Size Estimates and Forecasts
1.4.1 Global Pharmaceutical Excipients for Non-injection Revenue 2020-2031
1.4.2 Global Pharmaceutical Excipients for Non-injection Sales 2020-2031
1.4.3 Global Pharmaceutical Excipients for Non-injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Pharmaceutical Excipients for Non-injection Market Competition by Manufacturers
2.1 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Pharmaceutical Excipients for Non-injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Pharmaceutical Excipients for Non-injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Product Type & Application
2.7 Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Date of Enter into This Industry
2.8 Global Pharmaceutical Excipients for Non-injection Market Competitive Situation and Trends
2.8.1 Global Pharmaceutical Excipients for Non-injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Pharmaceutical Excipients for Non-injection Players Market Share by Revenue
2.8.3 Global Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Pharmaceutical Excipients for Non-injection Market Scenario by Region
3.1 Global Pharmaceutical Excipients for Non-injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2020-2031
3.2.1 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2020-2025
3.2.2 Global Pharmaceutical Excipients for Non-injection Sales by Region: 2026-2031
3.3 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2020-2031
3.3.1 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2020-2025
3.3.2 Global Pharmaceutical Excipients for Non-injection Revenue by Region: 2026-2031
3.4 North America Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.4.1 North America Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.4.3 North America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.5.1 Europe Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.5.3 Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharmaceutical Excipients for Non-injection Market Facts & Figures by Region
3.6.1 Asia Pacific Pharmaceutical Excipients for Non-injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.7.1 Latin America Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.7.3 Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharmaceutical Excipients for Non-injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharmaceutical Excipients for Non-injection Sales by Type (2020-2031)
4.1.1 Global Pharmaceutical Excipients for Non-injection Sales by Type (2020-2025)
4.1.2 Global Pharmaceutical Excipients for Non-injection Sales by Type (2026-2031)
4.1.3 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2020-2031)
4.2 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2020-2031)
4.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2020-2025)
4.2.2 Global Pharmaceutical Excipients for Non-injection Revenue by Type (2026-2031)
4.2.3 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2020-2031)
4.3 Global Pharmaceutical Excipients for Non-injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Pharmaceutical Excipients for Non-injection Sales by Application (2020-2031)
5.1.1 Global Pharmaceutical Excipients for Non-injection Sales by Application (2020-2025)
5.1.2 Global Pharmaceutical Excipients for Non-injection Sales by Application (2026-2031)
5.1.3 Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2020-2031)
5.2 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2020-2031)
5.2.1 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2020-2025)
5.2.2 Global Pharmaceutical Excipients for Non-injection Revenue by Application (2026-2031)
5.2.3 Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2020-2031)
5.3 Global Pharmaceutical Excipients for Non-injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Dow
6.1.1 Dow Company Information
6.1.2 Dow Description and Business Overview
6.1.3 Dow Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Dow Pharmaceutical Excipients for Non-injection Product Portfolio
6.1.5 Dow Recent Developments/Updates
6.2 Nippon Fine Chemical
6.2.1 Nippon Fine Chemical Company Information
6.2.2 Nippon Fine Chemical Description and Business Overview
6.2.3 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product Portfolio
6.2.5 Nippon Fine Chemical Recent Developments/Updates
6.3 Nanjing Well Pharmaceutical
6.3.1 Nanjing Well Pharmaceutical Company Information
6.3.2 Nanjing Well Pharmaceutical Description and Business Overview
6.3.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.3.5 Nanjing Well Pharmaceutical Recent Developments/Updates
6.4 Jiangsu Maxim Biological
6.4.1 Jiangsu Maxim Biological Company Information
6.4.2 Jiangsu Maxim Biological Description and Business Overview
6.4.3 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product Portfolio
6.4.5 Jiangsu Maxim Biological Recent Developments/Updates
6.5 NOF
6.5.1 NOF Company Information
6.5.2 NOF Description and Business Overview
6.5.3 NOF Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NOF Pharmaceutical Excipients for Non-injection Product Portfolio
6.5.5 NOF Recent Developments/Updates
6.6 Croda
6.6.1 Croda Company Information
6.6.2 Croda Description and Business Overview
6.6.3 Croda Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Croda Pharmaceutical Excipients for Non-injection Product Portfolio
6.6.5 Croda Recent Developments/Updates
6.7 Jiangsu Poly Pharmaceutical
6.7.1 Jiangsu Poly Pharmaceutical Company Information
6.7.2 Jiangsu Poly Pharmaceutical Description and Business Overview
6.7.3 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.7.5 Jiangsu Poly Pharmaceutical Recent Developments/Updates
6.8 Er Kang Pharmaceutical
6.8.1 Er Kang Pharmaceutical Company Information
6.8.2 Er Kang Pharmaceutical Description and Business Overview
6.8.3 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.8.5 Er Kang Pharmaceutical Recent Developments/Updates
6.9 Guangzhou Hanfang Pharmaceutical
6.9.1 Guangzhou Hanfang Pharmaceutical Company Information
6.9.2 Guangzhou Hanfang Pharmaceutical Description and Business Overview
6.9.3 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.9.5 Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
6.10 Pfanstiehl
6.10.1 Pfanstiehl Company Information
6.10.2 Pfanstiehl Description and Business Overview
6.10.3 Pfanstiehl Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Pfanstiehl Pharmaceutical Excipients for Non-injection Product Portfolio
6.10.5 Pfanstiehl Recent Developments/Updates
6.11 Xi'an Libang Pharmaceutical
6.11.1 Xi'an Libang Pharmaceutical Company Information
6.11.2 Xi'an Libang Pharmaceutical Description and Business Overview
6.11.3 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product Portfolio
6.11.5 Xi'an Libang Pharmaceutical Recent Developments/Updates
6.12 Zhejiang Tianyushan Medicinal Oil
6.12.1 Zhejiang Tianyushan Medicinal Oil Company Information
6.12.2 Zhejiang Tianyushan Medicinal Oil Description and Business Overview
6.12.3 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product Portfolio
6.12.5 Zhejiang Tianyushan Medicinal Oil Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharmaceutical Excipients for Non-injection Industry Chain Analysis
7.2 Pharmaceutical Excipients for Non-injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharmaceutical Excipients for Non-injection Production Mode & Process Analysis
7.4 Pharmaceutical Excipients for Non-injection Sales and Marketing
7.4.1 Pharmaceutical Excipients for Non-injection Sales Channels
7.4.2 Pharmaceutical Excipients for Non-injection Distributors
7.5 Pharmaceutical Excipients for Non-injection Customer Analysis
8 Pharmaceutical Excipients for Non-injection Market Dynamics
8.1 Pharmaceutical Excipients for Non-injection Industry Trends
8.2 Pharmaceutical Excipients for Non-injection Market Drivers
8.3 Pharmaceutical Excipients for Non-injection Market Challenges
8.4 Pharmaceutical Excipients for Non-injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pharmaceutical Excipients for Non-injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pharmaceutical Excipients for Non-injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pharmaceutical Excipients for Non-injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pharmaceutical Excipients for Non-injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pharmaceutical Excipients for Non-injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Product Type & Application
Table 12. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical Excipients for Non-injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients for Non-injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Excipients for Non-injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pharmaceutical Excipients for Non-injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical Excipients for Non-injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2026-2031)
Table 21. Global Pharmaceutical Excipients for Non-injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2020-2025)
Table 23. Global Pharmaceutical Excipients for Non-injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2026-2031)
Table 25. North America Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2025)
Table 51. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2026-2031)
Table 52. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2020-2025)
Table 53. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2026-2031)
Table 54. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2020-2025)
Table 57. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2026-2031)
Table 58. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2020-2025)
Table 61. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2026-2031)
Table 62. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2020-2025)
Table 63. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2026-2031)
Table 64. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2020-2025)
Table 67. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2026-2031)
Table 68. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2026-2031)
Table 70. Dow Company Information
Table 71. Dow Description and Business Overview
Table 72. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Dow Pharmaceutical Excipients for Non-injection Product
Table 74. Dow Recent Developments/Updates
Table 75. Nippon Fine Chemical Company Information
Table 76. Nippon Fine Chemical Description and Business Overview
Table 77. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product
Table 79. Nippon Fine Chemical Recent Developments/Updates
Table 80. Nanjing Well Pharmaceutical Company Information
Table 81. Nanjing Well Pharmaceutical Description and Business Overview
Table 82. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 84. Nanjing Well Pharmaceutical Recent Developments/Updates
Table 85. Jiangsu Maxim Biological Company Information
Table 86. Jiangsu Maxim Biological Description and Business Overview
Table 87. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product
Table 89. Jiangsu Maxim Biological Recent Developments/Updates
Table 90. NOF Company Information
Table 91. NOF Description and Business Overview
Table 92. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. NOF Pharmaceutical Excipients for Non-injection Product
Table 94. NOF Recent Developments/Updates
Table 95. Croda Company Information
Table 96. Croda Description and Business Overview
Table 97. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Croda Pharmaceutical Excipients for Non-injection Product
Table 99. Croda Recent Developments/Updates
Table 100. Jiangsu Poly Pharmaceutical Company Information
Table 101. Jiangsu Poly Pharmaceutical Description and Business Overview
Table 102. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 104. Jiangsu Poly Pharmaceutical Recent Developments/Updates
Table 105. Er Kang Pharmaceutical Company Information
Table 106. Er Kang Pharmaceutical Description and Business Overview
Table 107. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 109. Er Kang Pharmaceutical Recent Developments/Updates
Table 110. Guangzhou Hanfang Pharmaceutical Company Information
Table 111. Guangzhou Hanfang Pharmaceutical Description and Business Overview
Table 112. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 114. Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
Table 115. Pfanstiehl Company Information
Table 116. Pfanstiehl Description and Business Overview
Table 117. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Pfanstiehl Pharmaceutical Excipients for Non-injection Product
Table 119. Pfanstiehl Recent Developments/Updates
Table 120. Xi'an Libang Pharmaceutical Company Information
Table 121. Xi'an Libang Pharmaceutical Description and Business Overview
Table 122. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 124. Xi'an Libang Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Tianyushan Medicinal Oil Company Information
Table 126. Zhejiang Tianyushan Medicinal Oil Description and Business Overview
Table 127. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product
Table 129. Zhejiang Tianyushan Medicinal Oil Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Pharmaceutical Excipients for Non-injection Distributors List
Table 133. Pharmaceutical Excipients for Non-injection Customers List
Table 134. Pharmaceutical Excipients for Non-injection Market Trends
Table 135. Pharmaceutical Excipients for Non-injection Market Drivers
Table 136. Pharmaceutical Excipients for Non-injection Market Challenges
Table 137. Pharmaceutical Excipients for Non-injection Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Excipients for Non-injection
Figure 2. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Excipients for Non-injection Market Share by Type: 2024 & 2031
Figure 4. Binders Product Picture
Figure 5. Disintegrants Product Picture
Figure 6. Lubricants Product Picture
Figure 7. Fillers Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pharmaceutical Excipients for Non-injection Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Pharmaceutical Excipients for Non-injection Market Share by Application: 2024 & 2031
Figure 11. Tablets
Figure 12. Capsules
Figure 13. Oral Liquids
Figure 14. Others
Figure 15. Global Pharmaceutical Excipients for Non-injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Pharmaceutical Excipients for Non-injection Market Size (2020-2031) & (US$ Million)
Figure 17. Global Pharmaceutical Excipients for Non-injection Sales (2020-2031) & (K Units)
Figure 18. Global Pharmaceutical Excipients for Non-injection Average Price (US$/Unit) & (2020-2031)
Figure 19. Pharmaceutical Excipients for Non-injection Report Years Considered
Figure 20. Pharmaceutical Excipients for Non-injection Sales Share by Manufacturers in 2024
Figure 21. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Pharmaceutical Excipients for Non-injection Players: Market Share by Revenue in Pharmaceutical Excipients for Non-injection in 2024
Figure 23. Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Pharmaceutical Excipients for Non-injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 26. North America Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 27. United States Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 30. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 31. Germany Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2020-2031)
Figure 38. China Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 46. Latin America Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Pharmaceutical Excipients for Non-injection by Type (2020-2031)
Figure 56. Global Revenue Market Share of Pharmaceutical Excipients for Non-injection by Type (2020-2031)
Figure 57. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Pharmaceutical Excipients for Non-injection by Application (2020-2031)
Figure 59. Global Revenue Market Share of Pharmaceutical Excipients for Non-injection by Application (2020-2031)
Figure 60. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2020-2031)
Figure 61. Pharmaceutical Excipients for Non-injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Pharmaceutical Excipients for Non-injection Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Pharmaceutical Excipients for Non-injection Market Competitive Situation by Manufacturers in 2024
Table 4. Global Pharmaceutical Excipients for Non-injection Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Pharmaceutical Excipients for Non-injection Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Pharmaceutical Excipients for Non-injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Product Type & Application
Table 12. Global Key Manufacturers of Pharmaceutical Excipients for Non-injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pharmaceutical Excipients for Non-injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Excipients for Non-injection as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Excipients for Non-injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Pharmaceutical Excipients for Non-injection Sales by Region (2020-2025) & (K Units)
Table 18. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2020-2025)
Table 19. Global Pharmaceutical Excipients for Non-injection Sales by Region (2026-2031) & (K Units)
Table 20. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2026-2031)
Table 21. Global Pharmaceutical Excipients for Non-injection Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2020-2025)
Table 23. Global Pharmaceutical Excipients for Non-injection Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2026-2031)
Table 25. North America Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 27. North America Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 28. North America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 32. Europe Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 33. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Pharmaceutical Excipients for Non-injection Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2020-2025)
Table 51. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Type (2026-2031)
Table 52. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2020-2025)
Table 53. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Type (2026-2031)
Table 54. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2020-2025)
Table 57. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Type (2026-2031)
Table 58. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2020-2025)
Table 59. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2026-2031)
Table 60. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2020-2025)
Table 61. Global Pharmaceutical Excipients for Non-injection Sales (K Units) by Application (2026-2031)
Table 62. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2020-2025)
Table 63. Global Pharmaceutical Excipients for Non-injection Sales Market Share by Application (2026-2031)
Table 64. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Pharmaceutical Excipients for Non-injection Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2020-2025)
Table 67. Global Pharmaceutical Excipients for Non-injection Revenue Market Share by Application (2026-2031)
Table 68. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2020-2025)
Table 69. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2026-2031)
Table 70. Dow Company Information
Table 71. Dow Description and Business Overview
Table 72. Dow Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Dow Pharmaceutical Excipients for Non-injection Product
Table 74. Dow Recent Developments/Updates
Table 75. Nippon Fine Chemical Company Information
Table 76. Nippon Fine Chemical Description and Business Overview
Table 77. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Nippon Fine Chemical Pharmaceutical Excipients for Non-injection Product
Table 79. Nippon Fine Chemical Recent Developments/Updates
Table 80. Nanjing Well Pharmaceutical Company Information
Table 81. Nanjing Well Pharmaceutical Description and Business Overview
Table 82. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Nanjing Well Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 84. Nanjing Well Pharmaceutical Recent Developments/Updates
Table 85. Jiangsu Maxim Biological Company Information
Table 86. Jiangsu Maxim Biological Description and Business Overview
Table 87. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Jiangsu Maxim Biological Pharmaceutical Excipients for Non-injection Product
Table 89. Jiangsu Maxim Biological Recent Developments/Updates
Table 90. NOF Company Information
Table 91. NOF Description and Business Overview
Table 92. NOF Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. NOF Pharmaceutical Excipients for Non-injection Product
Table 94. NOF Recent Developments/Updates
Table 95. Croda Company Information
Table 96. Croda Description and Business Overview
Table 97. Croda Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Croda Pharmaceutical Excipients for Non-injection Product
Table 99. Croda Recent Developments/Updates
Table 100. Jiangsu Poly Pharmaceutical Company Information
Table 101. Jiangsu Poly Pharmaceutical Description and Business Overview
Table 102. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Jiangsu Poly Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 104. Jiangsu Poly Pharmaceutical Recent Developments/Updates
Table 105. Er Kang Pharmaceutical Company Information
Table 106. Er Kang Pharmaceutical Description and Business Overview
Table 107. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Er Kang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 109. Er Kang Pharmaceutical Recent Developments/Updates
Table 110. Guangzhou Hanfang Pharmaceutical Company Information
Table 111. Guangzhou Hanfang Pharmaceutical Description and Business Overview
Table 112. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Guangzhou Hanfang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 114. Guangzhou Hanfang Pharmaceutical Recent Developments/Updates
Table 115. Pfanstiehl Company Information
Table 116. Pfanstiehl Description and Business Overview
Table 117. Pfanstiehl Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Pfanstiehl Pharmaceutical Excipients for Non-injection Product
Table 119. Pfanstiehl Recent Developments/Updates
Table 120. Xi'an Libang Pharmaceutical Company Information
Table 121. Xi'an Libang Pharmaceutical Description and Business Overview
Table 122. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Xi'an Libang Pharmaceutical Pharmaceutical Excipients for Non-injection Product
Table 124. Xi'an Libang Pharmaceutical Recent Developments/Updates
Table 125. Zhejiang Tianyushan Medicinal Oil Company Information
Table 126. Zhejiang Tianyushan Medicinal Oil Description and Business Overview
Table 127. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Zhejiang Tianyushan Medicinal Oil Pharmaceutical Excipients for Non-injection Product
Table 129. Zhejiang Tianyushan Medicinal Oil Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Pharmaceutical Excipients for Non-injection Distributors List
Table 133. Pharmaceutical Excipients for Non-injection Customers List
Table 134. Pharmaceutical Excipients for Non-injection Market Trends
Table 135. Pharmaceutical Excipients for Non-injection Market Drivers
Table 136. Pharmaceutical Excipients for Non-injection Market Challenges
Table 137. Pharmaceutical Excipients for Non-injection Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pharmaceutical Excipients for Non-injection
Figure 2. Global Pharmaceutical Excipients for Non-injection Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmaceutical Excipients for Non-injection Market Share by Type: 2024 & 2031
Figure 4. Binders Product Picture
Figure 5. Disintegrants Product Picture
Figure 6. Lubricants Product Picture
Figure 7. Fillers Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pharmaceutical Excipients for Non-injection Market Value by Application (2020-2031) & (US$ Million)
Figure 10. Global Pharmaceutical Excipients for Non-injection Market Share by Application: 2024 & 2031
Figure 11. Tablets
Figure 12. Capsules
Figure 13. Oral Liquids
Figure 14. Others
Figure 15. Global Pharmaceutical Excipients for Non-injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Pharmaceutical Excipients for Non-injection Market Size (2020-2031) & (US$ Million)
Figure 17. Global Pharmaceutical Excipients for Non-injection Sales (2020-2031) & (K Units)
Figure 18. Global Pharmaceutical Excipients for Non-injection Average Price (US$/Unit) & (2020-2031)
Figure 19. Pharmaceutical Excipients for Non-injection Report Years Considered
Figure 20. Pharmaceutical Excipients for Non-injection Sales Share by Manufacturers in 2024
Figure 21. Global Pharmaceutical Excipients for Non-injection Revenue Share by Manufacturers in 2024
Figure 22. Global 5 and 10 Largest Pharmaceutical Excipients for Non-injection Players: Market Share by Revenue in Pharmaceutical Excipients for Non-injection in 2024
Figure 23. Pharmaceutical Excipients for Non-injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 24. Global Pharmaceutical Excipients for Non-injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 25. North America Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 26. North America Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 27. United States Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Canada Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Europe Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 30. Europe Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 31. Germany Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. France Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. U.K. Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Italy Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Russia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Asia Pacific Pharmaceutical Excipients for Non-injection Sales Market Share by Region (2020-2031)
Figure 37. Asia Pacific Pharmaceutical Excipients for Non-injection Revenue Market Share by Region (2020-2031)
Figure 38. China Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Japan Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. South Korea Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. India Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Australia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. China Taiwan Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Southeast Asia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Latin America Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 46. Latin America Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 47. Mexico Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Brazil Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Argentina Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Middle East and Africa Pharmaceutical Excipients for Non-injection Sales Market Share by Country (2020-2031)
Figure 51. Middle East and Africa Pharmaceutical Excipients for Non-injection Revenue Market Share by Country (2020-2031)
Figure 52. Turkey Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Saudi Arabia Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. UAE Pharmaceutical Excipients for Non-injection Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Global Sales Market Share of Pharmaceutical Excipients for Non-injection by Type (2020-2031)
Figure 56. Global Revenue Market Share of Pharmaceutical Excipients for Non-injection by Type (2020-2031)
Figure 57. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Type (2020-2031)
Figure 58. Global Sales Market Share of Pharmaceutical Excipients for Non-injection by Application (2020-2031)
Figure 59. Global Revenue Market Share of Pharmaceutical Excipients for Non-injection by Application (2020-2031)
Figure 60. Global Pharmaceutical Excipients for Non-injection Price (US$/Unit) by Application (2020-2031)
Figure 61. Pharmaceutical Excipients for Non-injection Value Chain
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Advanced Enteric Capsules Market Research Report 2025
Jul 08, 25
Global Outdoor Structures and Chairs Market Research Report 2025
Jul 08, 25
Global Herbs Ingredients Market Research Report 2025
Jul 08, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232